These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4536639)

  • 1. Variable susceptibility of Hemophilus influenzae, type B strains to serum bactericidal activity.
    Norden CW
    Proc Soc Exp Biol Med; 1972 Jan; 139(1):59-61. PubMed ID: 4536639
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of human antibody to polyribophosphate, the capsular antigen of Hemophilus influenzae, type B.
    Johnston RB; Anderson P; Rosen FS; Smith DH
    Clin Immunol Immunopathol; 1973 Jan; 1(2):234-40. PubMed ID: 4543490
    [No Abstract]   [Full Text] [Related]  

  • 3. Human serum activities against Hemophilus influenzae, type b.
    Anderson P; Johnston RB; Smith DH
    J Clin Invest; 1972 Jan; 51(1):31-8. PubMed ID: 4536614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Counterimmunoelectrophoresis in Hemophilus influenzae type b epiglottitis and pericarditis.
    Smith EW; Ingram DL
    J Pediatr; 1975 Apr; 86(4):571-3. PubMed ID: 1079250
    [No Abstract]   [Full Text] [Related]  

  • 5. Fetal-neonatal passive immunization against Hemophilus influenzae, type b.
    Amstey MS; Insel R; Munoz J; Pichichero M
    Am J Obstet Gynecol; 1985 Nov; 153(6):607-11. PubMed ID: 3877464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Target antigens for bactericidal and opsonizing antibodies to Haemophilus influenzae.
    Dahlberg-Lagergård T
    Acta Pathol Microbiol Immunol Scand C; 1982 Aug; 90(4):209-16. PubMed ID: 6982592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunity to disease caused by Hemophilus influenzae type b. II. Specificity and some biologic characteristics of "natural," infection-acquired, and immunization-induced antibodies to the capsular polysaccharide of Hemophilus influenzae type b.
    Schneerson R; Rodrigues LP; Parke JC; Robbins JB
    J Immunol; 1971 Oct; 107(4):1081-9. PubMed ID: 5315273
    [No Abstract]   [Full Text] [Related]  

  • 8. Haemophilus influenzae type b: disease and immunity in humans.
    Ann Intern Med; 1973 Feb; 78(2):259-69. PubMed ID: 4567179
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunogenicity in weanling rabbits of a polyribophosphate complex from Haemophilus influenzae type b.
    Anderson P; Smith DH
    J Infect Dis; 1977 Aug; 136 Suppl():S63-70. PubMed ID: 302292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bactericidal antibodies to Hemophilus influenzae.
    Gump DW; Tarr P; Phillips CA; Forsyth BR
    Proc Soc Exp Biol Med; 1971 Oct; 138(1):76-80. PubMed ID: 4942191
    [No Abstract]   [Full Text] [Related]  

  • 11. Polyribophosphate, the type-specific substance of Hemophilus influenzae, type b.
    ZAMENHOF S; LEIDY G; FITZGERALD PL; ALEXANDER HE; CHARGAFF E
    J Biol Chem; 1953 Aug; 203(2):695-704. PubMed ID: 13084639
    [No Abstract]   [Full Text] [Related]  

  • 12. Haemophilus influenzae: immunology and immunoprotection.
    Solotorovsky M; Lynn M
    CRC Crit Rev Microbiol; 1978 Sep; 6(1):1-32. PubMed ID: 359242
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevention of Haemophilus influenzae type b disease in humans.
    Smith DH; Robbins JB
    Prev Med; 1974 Dec; 3(4):446-8. PubMed ID: 4548185
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunization of humans with polyribophosphate, the capsular antigen of Hemophilus influenzae, type b.
    Anderson P; Peter G; Johnston RB; Wetterlow LH; Smith DH
    J Clin Invest; 1972 Jan; 51(1):39-44. PubMed ID: 4536615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of Haemophilus influenzae type b capsular antibody in neonatal rabbits by gastrointestinal colonization with cross-reacting Escherichia coli.
    Myerowitz RL; Handzel ZT; Scheerson R; Robbins JB
    Infect Immun; 1973 Feb; 7(2):137-40. PubMed ID: 4572607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of antigens from nontypable Haemophilus influenzae recognized by human bactericidal antibodies. Role of Haemophilus outer membrane proteins.
    Gnehm HE; Pelton SI; Gulati S; Rice PA
    J Clin Invest; 1985 May; 75(5):1645-58. PubMed ID: 3873475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human serum bactericidal activity against Haemophilus influenzae type b.
    Stull TL; Jacobs RF; Haas JE; Roberts MC; Wilson CB; Smith AL
    J Gen Microbiol; 1984 Mar; 130(3):665-72. PubMed ID: 6374030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naturally occurring bactericidal antibodies specific for Haemophilus influenzae lipooligosaccharide are present in healthy adult individuals.
    Choi J; Nix EB; Gaultier GN; Cox AD; McCready W; Ulanova M
    Vaccine; 2015 Apr; 33(16):1941-7. PubMed ID: 25738817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of serum Haemophilus influenzae type B capsular antibodies in adult volunteers fed cross-reacting Escherichia coli 075:K100:H5.
    Schneerson R; Robbins JB
    N Engl J Med; 1975 May; 292(21):1093-6. PubMed ID: 48191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic value of the quantification of capsular antigens of haemophilus influenzae type b in the cerebrospinal fluid].
    Valvano MA; Grinstein S
    Medicina (B Aires); 1982; 42(5):475-82. PubMed ID: 6984876
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.